CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Imv Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Imv Inc
130 Eileen Stubbs Ave Suite 19
Phone: (902) 492-1819p:902 492-1819 DARTMOUTH, NS  B3B 2C4  Canada Ticker: IMVIQIMVIQ
Filed for Bankruptcy on 12/1/2023
This company ceased filing statements with the SEC on 9/22/2023.
On 11/29/2023, the Court granted the order (the “CCAA Termination Order”) granting the applicants or the Monitor on their behalf, the authority to authorize IMV Inc. to make an assignment in Bankruptcy under the Bankruptcy and Insolvency Act
On 12/1/2023, IMV Inc. and Immunovaccine Technologies Inc., each filed an assignment pursuant to section 49(1) of the Bankruptcy and Insolvency Act
FTI Consulting Canada Inc. was appointed as trustee of the Bankrupt Estates
Business Summary
IMV Inc. is a Canada-based company. The Company has no business operations.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202212/31/2022YesYesYes--

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Michael P.Bailey 56 6/29/2022 7/20/2020
Chief Executive Officer, Director AndrewHall 47 1/1/2022 11/9/2020
Acting Chief Financial Officer, Chief Accounting Officer BrittanyDavison 9/1/2022 9/1/2022
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Immunovaccine Technologies Inc. 1819 Granville Street Halifax NS Canada

Business Names
Business Name
Immunovaccine Technologies Inc. Nova Scotia, Canada
Immunovaccine, Inc.
Imv Inc
IMV USA Inc.
IMVIQ
Rhino Resources Inc.

General Information
Number of Employees: 63 (As of 12/31/2022)
Outstanding Shares: 11,711,637 (As of 3/15/2023)
Stock Exchange: OTC
Federal Tax Id: 847476991
Fax Number: (902) 492-0888


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024